Skip to content

STTK

Shattuck Labs, Inc.

NASDAQ · USHealthcareBiotechnology
$6.82-9.43%

Price as of Jul 20, 2026

STTK growth

Shattuck Labs, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
-78.3%
EBITDA
+34.4%
EBIT
+29.7%
EPS
+54.7%
Free cash flow
+26.9%
Operating cash flow
+26.8%

Forward estimates

Revenue
+606.6%
EBITDA
+84.7%
EPS
+36.6%

Three-year CAGR

Revenue
+15.3%
EBITDA
+37.0%
EBIT
+36.1%
Net income
+35.3%
EPS
+53.0%
Free cash flow
+34.0%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.